Urinalysis.
Wilson LA.
Nurs Stand. 2005 May 11-17;19(35):51-4. doi: 10.7748/ns2005.05.19.35.51.c3865.
Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
Nabais Sá MJ, Storey H, Flinter F, Nagel M, Sampaio S, Castro R, Araújo JA, Gaspar MA, Soares C, Oliveira A, Henriques AC, da Costa AG, Abreu CP, Ponce P, Alves R, Pinho L, Silva SE, de Moura CP, Mendonça L, Carvalho F, Pestana M, Alves S, Carvalho F, Oliveira JP.
Clin Genet. 2015 Nov;88(5):456-61. doi: 10.1111/cge.12521. Epub 2014 Nov 10.
Urinary DNA Methylation Test for Bladder Cancer Diagnosis.
Jeong IG, Yun SC, Ha HK, Kang SG, Lee S, Park S, Sung HH, Kim SI, Hwang EC, Moon KC, Kwak C.
JAMA Oncol. 2025 Mar 1;11(3):293-299. doi: 10.1001/jamaoncol.2024.6160.
Asymptomatic Microscopic Hematuria in Women.
[No authors listed]
Female Pelvic Med Reconstr Surg. 2017 Jul/Aug;23(4):228-231. doi: 10.1097/SPV.0000000000000432.
Screening for hematuria.
[No authors listed]
JAMA. 1990 Apr 4;263(13):1763-4.
Nephrolithiasis in children.
Valentini RP, Lakshmanan Y.
Adv Chronic Kidney Dis. 2011 Sep;18(5):370-5. doi: 10.1053/j.ackd.2011.07.002.
Screening for Microscopic Hematuria in a Urogynecologic Population.
Dune TJ, Kliethermes S, Mueller ER, Fitzgerald CM, Brubaker L, Brincat CA.
Female Pelvic Med Reconstr Surg. 2020 Jun;26(6):382-386. doi: 10.1097/SPV.0000000000000733.
Benefit of urinalysis.
Shajari A, Shajari H, Zade MH, Kamali K, Kadivar MR, Nourani F.
Indian J Pediatr. 2009 Jun;76(6):639-41. doi: 10.1007/s12098-009-0068-3. Epub 2009 Apr 23.
Urinary markers in screening patients with hematuria.
Chiong E, Gaston KE, Grossman HB.
World J Urol. 2008 Feb;26(1):25-30. doi: 10.1007/s00345-007-0229-9. Epub 2007 Dec 4.
Persistent prostatic hematuria.
Rastinehad AR, Ost MC, VanderBrink BA, Siegel DN, Kavoussi LR.
Nat Clin Pract Urol. 2008 Mar;5(3):159-65. doi: 10.1038/ncpuro1044.
